The information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the U.S. Securities and Exchange Commission is effective. The preliminary prospectus is not an offer to sell these securities and does not constitute the solicitation of offers to buy these securities in any jurisdiction where the offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED MAY 19, 2021
GCM GROSVENOR INC.
172,538,315 SHARES OF CLASS A COMMON STOCK
2,700,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK AND
23,893,798 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS
This prospectus relates to the resale from time to time of (i) an aggregate of 172,538,315 shares of Class A common stock, par value $0.0001 per share (the “Class A common stock”), of GCM Grosvenor Inc., a Delaware corporation, including shares of Class A common stock we may issue from time to time to the GCMH Equityholders (as defined below) upon the exchange by such stockholders of an equivalent number of Grosvenor common units (as defined herein) and (ii) 2,700,000 warrants to purchase Class A common stock at an exercise price of $11.50 per share (the “warrants”) by the selling shareholders named in this prospectus (each a “Selling Shareholder” and, collectively, the “Selling Shareholders”). This prospectus also relates to the issuance by us of up to 23,893,798 shares of Class A common stock upon the exercise of outstanding warrants.
On November 17, 2020, we consummated the business combination (the “Business Combination”) contemplated by that certain transaction agreement, dated as of August 2, 2020 (as may be amended from time to time, the “Transaction Agreement”), by and among CF Finance Acquisition Corp., a Delaware corporation (“CFAC”), GCM Grosvenor Holdings, LLC (formerly known as CF Finance Intermediate Acquisition, LLC), a Delaware limited liability company, CF Finance Holdings, LLC, a Delaware limited liability company (the “CF Sponsor”), Grosvenor Capital Management Holdings, LLLP, a Delaware limited liability limited partnership, Grosvenor Holdings, L.L.C., an Illinois limited liability company (“Holdings”), GCM Grosvenor Management, LLC, a Delaware limited liability company (“Grosvenor Management”), Grosvenor Holdings II, L.L.C., a Delaware limited liability company (together with Holdings and Grosvenor Management, the “GCMH Equityholders”), GCMH GP, L.L.C., a Delaware limited liability company, GCM V, LLC, a Delaware limited liability company, and us, pursuant to which, among other transactions, CFAC merged with and into us, upon which the separate corporate existence of CFAC ceased and we became the surviving corporation.
We are registering the resale of shares of Class A common stock and warrants as required by an amended and restated registration rights agreement, dated as of November 17, 2020 (the “Registration Rights Agreement”), entered into by and among us, the CF Sponsor, the GCMH Equityholders and certain qualified institutional buyers and accredited investors that purchased shares of Class A common stock in private placements consummated in connection with the Business Combination.
We will receive the proceeds from any exercise of the warrants for cash, but not from the resale of the shares of Class A common stock or warrants by the Selling Shareholders.
We will bear all costs, expenses and fees in connection with the registration of the shares of Class A common stock and warrants. The Selling Shareholders will bear all commissions and discounts, if any, attributable to their respective sales of the shares of Class A common stock and warrants.
Our shares of Class A common stock are listed on The Nasdaq Global Market under the symbol “GCMG.” On May 18, 2021, the closing sale price of shares of our Class A common stock was $12.64. Our warrants are listed on The Nasdaq Global Market under the symbol “GCMGW.” On May 18, 2021, the closing sale price of our warrants was $1.95.
Investing in shares of our Class A common stock or warrants involves risks that are described in the “Risk Factors” section beginning on page
3 of this prospectus.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the securities to be issued under this prospectus or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus is , 2021.